Loading…

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

07: ProjMgt-StrategicPlanning [clear filter]
Monday, June 24
 

11:00am

#114: Patient Perspective Diversity: Taking Cultural Differences in Patient Views Into Consideration in US, EU, and Japan
Component Type: Forum
Level: Basic
CE: ACPE 1.00 Knowledge UAN: 0286-0000-19-528-L04-P; CME 1.00; IACET 1.00; PDU 1.00 PMI 2166ASOAHB; RN 1.00

This session will discuss potential cultural impacts on various patient engagement processes, especially in US, UK and Japan. Presenters will briefly overview the contextual differences, such as medical system, provide actual cases, and facilitate the participants to identify tips to listen to patients globally, in order to incorporate those into global drug development.

Learning Objectives

Describe general patient practice and value differences (including in patient-doctor relationships) between Eastern culture and Western culture, and also understand the background to those differences; Identify potential opportunities and limitations to leverage patient voices in different cultures; Discuss further incorporating global diverse patient voices into drug development.

Chair

Atsushi Tsukamoto, PhD

Speaker

Nurse Point of View
Noriko Fujiwara, MS, RN

Intercultural Point of View (UK)
Gareth Julian Monteath, PhD, MBA, MS

USA Point of View
Robert Hilke, MA



Speakers
avatar for Noriko Fujiwara

Noriko Fujiwara

Research Nurse, Project Researcher, Department of Palliative Medicine, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo
Ms. Noriko Fujiwara is a research nurse and a project researcher of the department of palliative medicine, the Institute of Medical Science, the University of Tokyo. She has over 10 years' experience in research field. She is a Certified Nurse Specialist in Cancer Nursing with the... Read More →
avatar for Atsushi Tsukamoto

Atsushi Tsukamoto

Vice President, New Drug Regulatory Affairs, Daiichi Sankyo Co., Ltd.
Atsushi is VP of New Drug Regulatory Affairs (RA) at Daiichi Sankyo. He is also Head of Specialty Medicine RA in R&D division, to lead gobal specialty medicine regulatory strategies. As Head of Japan New Drug RA, he is responsible for leading new drug RA activities for all projects... Read More →
avatar for Robert Hilke

Robert Hilke

Chief Executive Officer, Hilke Communications Corporation
Robert Hilke is the CEO of Hilke Communications Corporation, a firm specializing in providing intercultural communications and TOEIC training for global businesspeople, many of whom work in the pharmaceutical industry. Mr. Hilke's primary research interest is the management of diverse... Read More →
avatar for Gaz Monteath

Gaz Monteath

Executive Director, Link Global Solution Inc.
Dr. Gareth ("Gaz") Monteath is Executive Director at Link Global Solution Inc., an HR and OD consulting firm based in Tokyo. In his position, Gaz is responsible for the overall content and quality of programmes. LGS has long experience of working with pharmaceutical and medical instruments... Read More →


Monday June 24, 2019 11:00am - 12:00pm
Room 15AB San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA

2:15pm

#144: Ready or Not: Business Continuity Planning
Component Type: Forum
Level: Advanced
CE: ACPE 1.00 Knowledge UAN: 0286-0000-19-544-L04-P; CME 1.00; IACET 1.00; PDU 1.00 PMI 2166VN1HY6; RN 1.00

This panel discussion will discuss business continuity planning as a key operational tool across the healthcare ecosystem, with a focus on biopharmaceutical companies. Representatives with experience across a variety of companies will share their insights and experiences with business continuity planning.

Learning Objectives

Assess which business processes are most critical to maintain in the event of a business disruption, key steps in developing business continuity plans, and linkages to risk management and crisis management.

Chair

Leigh Shultz, PhD, PMP

Speaker

Panelist
Jinus Moghbeli Pashai

Panelist
Mobeen Faqih, PhD, MBA

Panelist
Colleen Merritt Severyn, PhD



Speakers
MF

Mobeen Faqih

Lead - Business Continuity (Supply Chain), Bristol-Myers Squibb
Highly accomplished leader with over 14 years of professional experience in the pharmaceutical industry across multiple functional groups. As a Strategic Product Leader, developed and led global teams for product launch and life cycle management, supplier performance and relationship... Read More →
avatar for Jinus Moghbeli Pashai

Jinus Moghbeli Pashai

Director of Risk Managament, Amgen
CS

Colleen Severyn

Director, Business Development, Supplier and Alliance Management, GRA, Merck & Co., Inc.
Colleen Merritt Severyn is director of Merck Global Regulatory Affairs and Clinical Safety (GRACS). Colleen currently leads the Business Continuity Program and GRACS Innovation Council. She has 17 years of project, portfolio and change management leadership experience. Previously... Read More →
avatar for Leigh Shultz

Leigh Shultz

Associate Vice President, Global Project and Alliance Management, Merck & Co., Inc.
Global R&D Project & Alliance Management at Merck, leading the R&D Project Management (non-oncology) and Alliance Management (all therapeutic areas). PhD in chemistry; started at Merck in 2001 as a chemist in Pharm R&D. Joined Project Management in 2004; PMP-certified in 2007.


Monday June 24, 2019 2:15pm - 3:15pm
Room 15AB San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA

3:30pm

#155: Incorporating Systems-Theory and Human Factors into the Investigations of Serious Harm in Clinical Research
Component Type: Session
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-19-570-L04-P; CME 1.00; IACET 1.00; RN 1.00

This session will discuss how to complement existing activities and regulations, we propose an additional approach blending evidence derived from pharmacological and organizational science which addresses human factors and transparency to enhance organizational learning and continuous improvement. This systems approach should be seen as an additional way to understand how problems occur and how they might be prevented in the future.

Learning Objectives

Identify evidence-based techniques for better defining causal factors in system failure; Recognize that those techniques which can be used now; Appraise how we should best develop these concepts, identify best practice and engage all stakeholders; Discuss how to volunteer to join the team aiming to improve the safety of the system for clinical research.

Chair

Brian Edwards, DrMed

Speaker

Applying CAUSAL Analysis System Theory to the TGN1412 First-In-Human Clinical Trial
Brian Edwards, DrMed

Innovation in First-in-Human Safety
Howard Greenberg, DrMed, MD, MBA, MS

Investigators from the Warfarin-Stimulated Frail Hospitalized Patients Project
Nichola Crust, MSc



Speakers
NC

Nichola Crust

National Investigator, Healthcare Safety Investigation Branch
Nichola has worked at a strategic level in a variety of healthcare settings spanning primary and secondary care. Her roles have included professional nurse leadership and mentoring of nursing teams, mobilisation of new services including service and workforce redesign, and training... Read More →
avatar for Brian Edwards

Brian Edwards

Principal Consultant, Pharmacovigilance and Drug Safety, Vice-President ACRES, NDA Group
After his training in hospital medicine and clinical research for 14 years, Dr. Edwards joined the UK Medicines Control Agency (MHRA) in 1994 where he had various responsibilities as a pharmacovigilance assessor. In 1999 he joined Parexel to become Senior Medical Director before joining... Read More →
avatar for Howard Greenberg

Howard Greenberg

Medical Safety Officer, Janssen Research and Development, LLC
Dr. Greenberg is a Medical Safety Officer for Janssen Pharmaceuticals R&D, and Adjunct Associate Professor in the Department of Pharmacology & Experimental Therapeutics of Thomas Jefferson University. He is a Clinical Pharmacologist with education and experience in chemical engineering... Read More →


Monday June 24, 2019 3:30pm - 4:30pm
Room 6D San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA
  • Level Intermediate
  • Featured Topics What's Next,Patient Focused
  • Credit Type ACPE, CME, IACET, RN
  • Tags Session

3:30pm

#163: Strategic Integration: Is Anyone Getting it Right?
Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-19-560-L04-P; CME 1.00; IACET 1.00; PDU 1.00 PMI 2166060YI7; RN 1.00

Despite the regularity of asset or company acquisitions, integration into an existing portfolio is rarely straightforward. This forum will discuss successful (and less successful) strategies for integration across various healthcare organizations.

Learning Objectives

Describe the different components that lead to the successful integration of acquired assets or companies; Compare and contrast different strategies for strategic integration and discuss best practices from a business development, project and portfolio management perspective to promote streamlined integration of an asset or company.

Chair

Erin Mulrooney, MSc

Speaker

Industry Perspective
Vijayalakshmi Agnani, MBA, MS

Industry Perspective
Erin Mulrooney, MSc

Integration of Cultures and Teams in a Hospital Setting
Elizabeth Somers, MS



Speakers
avatar for Vijayalakshmi Agnani

Vijayalakshmi Agnani

Associate Director, Transactions, Global Business Development and Licensing, Sanofi
Vijayalaksmi (Viju) Agnani is currently Associate Director, Transactions in the Global Business Development and Licensing team at Sanofi. In this role, she engages throughout all phases of business development and licensing activities to lead and manage the execution of strategic... Read More →
avatar for Erin Mulrooney

Erin Mulrooney

Associate Director, Project Management, Merck & Co., Inc.
Erin Mulrooney joined the Global Project and Alliance Management group at Merck in 2016 as an Associate Director. She specializes in the management of large-scale, complex collaborative projects in Discovery and Early Development. Prior to her transition to Project Management, she... Read More →
avatar for Erin Mulrooney

Erin Mulrooney

Director, Portfolio Management and Operations, Biocelerate
Erin Mulrooney joined the Global Project and Alliance Management group at Merck in 2016 as an Associate Director. She specializes in the management of large-scale, complex collaborative projects in Discovery and Early Development. Prior to her transition to Project Management, she... Read More →
avatar for Elizabeth Somers

Elizabeth Somers

Executive Director of Infectious Disease, Global Project and Alliance Management, Merck & Co., Inc.
Liz is an Executive Director of Infectious Diseases in Global Project and Alliance Management at Merck. In addition to accountability for the ID TA, she manages a team focused on Discovery collaborations which leverages her experience managing complex cross functional drug development... Read More →


Monday June 24, 2019 3:30pm - 4:30pm
Room 15AB San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA
 
Tuesday, June 25
 

8:00am

#210: Increasing Personal Resilience To Manage Change
Component Type: Workshop
Level: Basic
CE: ACPE 1.25 Application UAN: 0286-0000-19-578-L04-P; CME 1.25; IACET 1.25; PDU 1.25 PMI 2166FSI3MB; RN 1.25

This interactive workshop will help you to identify how your behaviors influence how ready you are to deal with and manage change. You will learn to recognize key factors of resilience and implement approaches to increase your personal resilience.

Learning Objectives

Discuss why change is difficult and how your change type impacts how you adapt; Recognize what resilience is, why it is so important and what are the key factors to increasing your personal resilience; Develop an action plan on managing your personal resilience.

Chair

Kim Przenioslo, PMP

Speaker

Increasing Personal Resilience To Manage Change
Ryan Bailey, MA



Speakers
avatar for Ryan Bailey

Ryan Bailey

Senior Clinical Researcher, Rho, Inc.
Ryan Bailey, Senior Clinical Researcher, has over 13 years experience coordinating multi-disciplinary clinical research teams. He is a corporate leader for communication, innovation, and project management. His current interests within clinical research include: change management... Read More →
avatar for Kim Przenioslo

Kim Przenioslo

Director, Global Regulatory Affairs & Clinical Safety, Strategy Realization Off, Merck & Co., Inc.
Kim Przenioslo, is a Director, Global Regulatory Affairs & Clinical Safety (GRACS) Strategy Realization Office at Merck & Co. Inc, based out of Rahway, New Jersey. Kim leads the GRACS Change Management Center of Excellence, focused on building organizational capability, while driving... Read More →


Tuesday June 25, 2019 8:00am - 9:15am
Room 15AB San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA

10:30am

#238: Build and Leverage Your Networks to Influence Stakeholders
Component Type: Forum
Level: Basic
CE: ACPE 1.00 Application UAN: 0286-0000-19-597-L04-P; CME 1.00; IACET 1.00; PDU 1.00 PMI 2166OO2I8F; RN 1.00

Most project managers have to lead the project teams without positional authority. Learn how to cultivate a network of relationships whose influence can used to achieve personal and project success.

Learning Objectives

Describe your projects and explain how to expand your networks to include key influencers; Discuss how to leverage your networks to achieve personal and project priorities.

Chair

Jayanthi Reddy

Speaker

Industry Perspective
Maureen McNamara, MBA

Academic Perspective
Nancy Slater, MBA, PMP



Speakers
MM

Maureen McNamara

Executive Director, Global Project Management and Leadership, Daiicho Sankyo
Maureen has over 30 years industry experience primarily in drug development project management. She is currently Executive Director of Global Project Management & Leadership at Daiichi Sankyo Inc where she is responsible for leading project and portfolio management. Prior to this... Read More →
JR

Jayanthi Reddy

Director, Global Project Management, Merck & Co., Inc.
Jay has over 20 years of pharmaceutical industry experience and over 14 years of project Management experience. She is currently the cardiovascular franchise leader within the Project Management group at Merck.
avatar for Nancy Slater

Nancy Slater

Senior Director, Portfolio Program Management Therapeutic Area Head, AbbVie, Inc.
Nancy Slater, MBA, PMP is Senior Director, Portfolio Program Management Therapeutic Area Head for Virology and General Medicines at AbbVie. Nancy has over 24 years of Project Management experience in drug development, strategic process improvement initiatives and global lifecycle... Read More →


Tuesday June 25, 2019 10:30am - 11:30am
Room 15AB San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA

2:00pm

#265: Decision Leadership: How Using a Structured Approach to Decision Making Can Help You Lead Teams Better
Component Type: Workshop
Level: Intermediate
CE: ACPE 1.25 Application UAN: 0286-0000-19-616-L04-P; CME 1.25; IACET 1.25; PDU 1.25 PMI 2166QAHX56; RN 1.25

This workshop will draw on best practice and case study examples to teach participants the basics of decisions science, with a focus on providing hands-on experience with a framework that can be immediately applied by participants at their organization.

Learning Objectives

Differentiate between decisions and outcomes; Identify the structural components of choice (decisions, uncertainties, values); Recognize decision problems and declare decision opportunities; Employ a proven decision framework for facilitating better decision making within project teams.

Chair

Tyler Ludlow, MBA


Speakers
avatar for Tyler Ludlow

Tyler Ludlow

Founder and Chief Decision Scientist, Decision Skills Institute
As a decision scientist, Tyler helps people turn decision burdens into opportunities for growth. After earning a degree in applied math and an MBA, Tyler studied decision science at Stanford. He then spent a decade helping leaders at global 500 firms (including top pharma companies... Read More →


Tuesday June 25, 2019 2:00pm - 3:15pm
Room 15AB San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA
  • Level Beginner
  • Featured Topics Student Programming
  • Credit Type ACPE, CME, IACET, PMI, RN
  • Tags Workshop

4:15pm

#292: Conversations with the Participant: Layperson Summaries and Return of Results
Component Type: Forum
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-19-634-L04-P; CME 1.25; IACET 1.25; PDU 1.25 PMI 2166MBS6XA; RN 1.25

In this forum, experts will explore the international patchwork of regulatory requirements and policy recommendations for improving trial participant engagement by publishing layperson summaries and returning research results.

Learning Objectives

Identify best practices in sharing study level trial results; Recognize how to plan for participant dialog in study design.

Chair

James Riddle, MS

Speaker

Panelist
Barbara E Bierer, MD

Panelist
Deborah E. Collyar



Speakers
avatar for Barbara Bierer

Barbara Bierer

Professor, Harvard Medical School
Barbara Bierer, M.D., a hematologist-oncologist, is Professor of Medicine at Harvard Medical School and the Brigham and Women’s Hospital (BWH). Dr. Bierer co-founded and now leads the Multi-Regional Clinical Trials Center of BWH and Harvard (MRCT Center, www.mrctcenter.org), a collaborative... Read More →
avatar for Deborah Collyar

Deborah Collyar

President, Patient Advocates In Research (PAIR)
Deborah Collyar has applied a wealth of leadership skills from her successful IT business career to help create patient-centered medical research and healthcare, after her first cancer diagnosis at the age of 32. She founded Patient Advocates In Research (PAIR) in 1996, “where research... Read More →
avatar for James Riddle

James Riddle

Vice President, Strategic Consulting, Advarra
James Riddle is the VP of Strategic Consulting for Advarra, where he employs his extensive experience managing large operations and technology teams in the human subject protection field to grow Advarra Consulting worldwide. Mr. Riddle is also a faculty member, mentor, and regular... Read More →
avatar for James Riddle

James Riddle

Vice President, Strategic Consulting, Advarra
James Riddle is the VP of Strategic Consulting for Advarra, where he employs his extensive experience managing large operations and technology teams in the human subject protection field to grow Advarra Consulting worldwide. Mr. Riddle is also a faculty member, mentor, and regular... Read More →


Tuesday June 25, 2019 4:15pm - 5:30pm
Room 15AB San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA
  • Level Advanced
  • Featured Topics Patient Focused
  • Credit Type ACPE, CME, IACET, PMI, RN
  • Tags Forum
 
Wednesday, June 26
 

8:00am

#310: Project Planning 101: Turning Strategy into Execution
Component Type: Workshop
Level: Basic
CE: ACPE 1.25 Knowledge UAN: 0286-0000-19-651-L04-P; CME 1.25; IACET 1.25; PDU 1.25 PMI 2166RVVC1X; RN 1.25

A successful project starts with good planning. This session will provide tool agnostic best practices for creating a credible, realistic timeline that will help your project team achieve its deliverables on time.

Learning Objectives

Describe fundamental components of at least one project management methodology for managing a project; Compare and contrast differences between project management approaches; Describe the various roles and responsibilities of project managers either in non-drug development projects or in junior roles.

Chair

Matthew Curin, PharmD

Speaker

Best Practices for Project Planning
Ken Hays, MBA



Speakers
avatar for Ken Hays

Ken Hays

Senior Project Management Consultant, Independent Consultant
Ken has been engaged in Project Management since 1992, with experience in IT, Data Communications, Medical Device R&D and manufacturing, Drug Development and Process Improvement initiatives. He has driven key changes to large and small Project Organizations globally. As a PMP and... Read More →


Wednesday June 26, 2019 8:00am - 9:15am
Room 15AB San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA

10:30am

#337: Application of Project Management Methodologies and Tools in NonProfit Institutions
Component Type: Session
Level: Basic
CE: ACPE 1.00 Knowledge UAN: 0286-0000-19-668-L04-P; CME 1.00; IACET 1.00; PDU 1.00 PMI 2166QWTSEW; RN 1.00

Effective project management is crucial to every organization to execute effectively on strategic goals. Yet it may be a relatively new concept to healthcare and research organizations. Assessment of the need and development of the "right size" solution to encourage collaborative decision making, good stakeholder communication and robust planning will be discussed.

Learning Objectives

Discuss the need for project and portfolio management and assessment in academic and nonprofit institutions and learn how to implement project management in a non-traditional setting; Illustrate the use of and construction tools in resourced constrained environments.

Chair

Elizabeth Somers, MS

Speaker

Benefits of Adapting Project Management Methodologies to Meet the Specific Needs of an Organization
Elizabeth Somers, MS

How to Adapt Traditional Project Management Methodology for Research Institutions
Neha Pannuri, PMP

Developing and Deploying a Resource Management System in a Non-Profit Vaccine Development and Implementation Organization
Rami Scharf, DrSc, MBA, MSc



Speakers
avatar for Neha Pannuri

Neha Pannuri

Project Manager, Icahn Institute At Mount Sinai
Neha is a Project Manager at the Icahn Institute of Data Science and Genomic Technology at the Mount Sinai Hospital in New York City. She is primarily involved in the management of a multitude of projects including NIH-funded grants, industry collaborations, and internal strategic... Read More →
RS

Rami Scharf

Director Project and Portfolio Management, CVIA, PATH
Rami Scharf began his professional career training as a biologist at the Technion – Israel Institute of Technology, earning a doctorate in applied microbiology. He started working in industry, honing his project management skills while applying science to complex environmental issues... Read More →
avatar for Elizabeth Somers

Elizabeth Somers

Executive Director of Infectious Disease, Global Project and Alliance Management, Merck & Co., Inc.
Liz is an Executive Director of Infectious Diseases in Global Project and Alliance Management at Merck. In addition to accountability for the ID TA, she manages a team focused on Discovery collaborations which leverages her experience managing complex cross functional drug development... Read More →


Wednesday June 26, 2019 10:30am - 11:30am
Room 15AB San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA

12:30pm

#348 CH: Project Managing Your Own Leadership Journey
Component Type: Workshop
Level: Intermediate

The majority of us are somewhere in the middle of our leadership journeys. This discussion will bring together people who can share the successes they've had while helping each other to identify ways to continue our collective growth as leaders

Learning Objectives

Discuss how to develop a leadership development plan for their growth; Identify gaps and opportunities for growth; Recognize different ways to contribute and be seen as a leader.

Chair

Matthew J Meitzner, MS


Speakers
avatar for Matthew Meitzner

Matthew Meitzner

Associate Director, Project Management, Merck & Co., Inc.
Matt Meitzner is an experienced project manager in the pharmaceutical and medical device industries.


Wednesday June 26, 2019 12:30pm - 1:00pm
Content Hub Sails Pav San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA

2:00pm

#364: Effective Portfolio Management of Assets Across an Organization
Component Type: Session
Level: Intermediate
CE: ACPE 1.25 Application UAN: 0286-0000-19-688-L04-P; CME 1.25; IACET 1.25; PDU 1.25 PMI 2166TTL5PH; RN 1.25

This session will share information on portfolio management from different perspectives: integration of an asset into an established portfolio and ensuring alignment with an established strategy; brand development to articulate differentiation and how to approach this component from a portfolio lens; and leadership techniques and skills needed to manage portfolios.

Learning Objectives

Discuss portfolio management from different perspectives: Identify how to integrate an asset into an established portfolio and ensure alignment with an established strategy; Describe brand development to articulate differentiation and how to approach this component from a portfolio lens; Describe leadership techniques and skills needed to manage portfolios.

Chair

Mark Kryah, PMP

Speaker

Integration of an Acquired Asset into the Drug Development Portfolio
Nathan R. Kreischer, MS, PMP

Building for Commercial Success in Clinical Development: Defining your Asset’s Brand Story to Build Equity and Understanding
Kirstin Dawson

Leadership Capabilities That Enable Effective Project and Portfolio Management
Daniel Patrick, MBA



Speakers
avatar for Kirstin Dawson

Kirstin Dawson

Vice President, Account Director, Addison Whitney, A Syneos Health Company
As the Vice President, Account Director in San Francisco for Addison Whitney, Kirstin leads day-to-day communication & direction for both client projects and the account services team. Her background in healthcare marketing and experience across multiple disease states give Kirstin... Read More →
avatar for Nathan Kreischer

Nathan Kreischer

Associate Director, Global Project and Alliance Management, Merck & Co., Inc.
Nathan is an Associate Director within Global Project & Alliance Management at Merck. He has over 12 years of experience in the Pharmaceutical industry spanning Basic Research, Sales, Clinical Research and Project/Program Management. He has successfully lead teams through strategy... Read More →
avatar for Mark Kryah

Mark Kryah

Senior Advisor/COO, Bio-Medicines Business Unit, Eli Lilly and Company
Mark Kryah has been leading projects from early to late phase development for over 20 years. He has extensive international and cross-cultural experience in CMC, clinical and global development, with multiple alliance collaborations and co-development partnerships. He has led numerous... Read More →
DP

Daniel Patrick

Principal Consultant, Daiichi Sankyo
Dan Patrick has more than 25 years of experience in the Life Sciences and Financial Services industries. He is presently Global Group Leader, R&D Program Management Office, at Daiichi Sankyo Co. (a global pharmaceutical company) where he is responsible for developing and implementing... Read More →


Wednesday June 26, 2019 2:00pm - 3:15pm
Room 15AB San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA

4:15pm

#386: Setting the Stage for Effective Stakeholder Collaboration
Component Type: Workshop
Level: Basic
CE: ACPE 1.25 Application UAN: 0286-0000-19-705-L04-P; CME 1.25; IACET 1.25; PDU 1.25 PMI 2166TG9SYO; RN 1.25

Speakers from a North Carolina playwrights' forum facilitate stage reading performances of clinical research scenarios. Attendees will be guided through empathy mapping exercises, providing practical and powerful tools for stakeholder management.

Learning Objectives

Describe the empathy map technique, related to stakeholder management; Identify how to participate in “stage” readings of original scripts of stakeholder interactions; Gain collaborative experience building empathy maps for stakeholders; Demonstrate technique's impact, through role play and performance, ideas for future practical application of technique in your own department and/or project.

Chair

M Christine Morris, MBA

Speaker

Facilitator
Marina Acosta Enslen

Facilitator
Lydia Sbityakov



Speakers
avatar for Marina Acosta Enslen

Marina Acosta Enslen

Clinical Team Lead, Rho, Inc
Marina Acosta Enslen has 19 years of experience in the clinical research industry, managing projects in the areas of regulatory and study site start-up, clinical monitoring, clinical operations, and training at various companies, including Novartis, GSK, Quintiles, Docs Global, and... Read More →
avatar for M Christine Morris

M Christine Morris

Executive Director, Transperfect Life Sciences Solutions
Christine Morris leads strategy for the Life Sciences Solutions division of TransPerfect. She has 25 years of business process, consulting, leadership, and life sciences industry experience, in technology companies, CROs, Pharmaceutical companies, and academic research organizations... Read More →
LS

Lydia Sbityakov

Playwright, Cary Playwrights' Forum
Lydia Craft Sbityakov is a co-founder and chair of the board of directors for the Cary Playwrights’ Forum, a 501(c)3 organization, based in Cary, North Carolina. CPF supports the development of emerging and established dramatic writers through the provision of educational workshops... Read More →


Wednesday June 26, 2019 4:15pm - 5:30pm
Room 15AB San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA